BioSyntech, Inc.
BSYI
$0.00
$0.000.00%
| 12/31/2009 | 09/30/2009 | ||||
|---|---|---|---|---|---|
| Revenue | -99.55% | 132.84% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -99.55% | 132.84% | |||
| Cost of Revenue | -97.46% | 84.90% | |||
| Gross Profit | -100.54% | 165.71% | |||
| SG&A Expenses | -53.70% | 87.18% | |||
| Depreciation & Amortization | 43.55% | -16.65% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -31.54% | 64.83% | |||
| Operating Income | 27.89% | -62.28% | |||
| Income Before Tax | 3.17% | -44.70% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 3.17% | -44.70% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 3.17% | -44.70% | |||
| EBIT | 27.89% | -62.28% | |||
| EBITDA | 28.95% | -66.51% | |||
| EPS Basic | 3.51% | -39.11% | |||
| Normalized Basic EPS | 4.08% | -39.01% | |||
| EPS Diluted | 3.51% | -39.11% | |||
| Normalized Diluted EPS | 4.08% | -39.01% | |||
| Average Basic Shares Outstanding | 0.61% | 4.07% | |||
| Average Diluted Shares Outstanding | 0.61% | 4.07% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
